CalciMedica is trading 5.8% down at $2.04 amid broader-market weakness, after closing at $2.17 on September 4, 2026.

  • The Nasdaq Composite fell 0.65% and the Dow declined 0.81%.
  • Stronger-than-expected U.S. jobs data lifted rate-hike concerns.
  • No new company-specific announcement or earnings release was identified for September 4; recent Nasdaq compliance news was positive but preceded this move.